首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗抑郁药米氮平对吉西他滨治疗胰腺癌模型的辅助作用
引用本文:贾林,尚鸳鸳.抗抑郁药米氮平对吉西他滨治疗胰腺癌模型的辅助作用[J].胰腺病学,2009(6):380-382.
作者姓名:贾林  尚鸳鸳
作者单位:广州医学院附属广州市第一人民医院消化内科,广州510180
基金项目:2006年广东省社会发展领域科技计划项且(63082)
摘    要:目的探讨抗抑郁药米氮平对吉西他滨治疗的胰腺癌移植瘤裸鼠进食量、体重和肿瘤生长的影响。方法24只胰腺癌裸鼠皮下移植瘤模型随机分为对照组、吉西他滨组(术后第1、4、7、10天腹腔注射吉西他滨100mg/kg体重)和联用组(吉西他滨组+米氮平10mg·kg^-1·d^-1灌胃,持续21d),每组8只。术后21d处死裸鼠,比较3组动物体重、进食量、肿瘤体积的变化。结果吉西他滨组具有显著的抗肿瘤生长作用,但存在显著的胃纳减少和体重降低等不良反应。术后第21天,联用组和吉西他滨组胰腺癌移植瘤体积无明显差异,抑瘤率分别为69.13%和71.60%(P〉0.05);联用组进食量(3.12±0.11)g、体重(14.68±0.42)g,稍高于吉西他滨组的(2.96±0.14)g和(14.38±0.61)g(P值均〉0.05),但显著低于对照组的(4.65±0.13)g和(17.46±0.52)g(P值均〈0.05)。结论吉西他滨化疗具有显著的抗胰腺癌作用,米氮平虽无显著增效作用,但可在一定程度上减轻大剂量吉西他滨化疔的不良反应。

关 键 词:胰腺肿瘤  抗抑郁药  药物疗法  联合  米氮平  吉西他滨

Adjunctive effects of Mirtazapine in nude mice with pancreatic cancer xenografts treated with Gemcitabine
JIA Lin,SHANG Yuan-Yuan.Adjunctive effects of Mirtazapine in nude mice with pancreatic cancer xenografts treated with Gemcitabine[J].Chinese JOurnal of Pancreatology,2009(6):380-382.
Authors:JIA Lin  SHANG Yuan-Yuan
Institution:.( Department of Digestive Diseases, First People's Municipal Hospital of Guangzhou, Guangzhou Medical College, Guangzhou 510180, China)
Abstract:Objective To investigate the effects of mirtazapine in combination with gemcitabine on food intake, body weight and tumor growth of human pancreatic carcinoma xenografts in nude mice. Methods 24 subcutaneous pancreatic cancer xenograft nude mice were randomly divided into control group, gemcitabine group (receiving 100 mg/kg gemcitabine i.p. on days 1,4, 7 and 10 after operation) and combination group (gemcitabine as above and mirtazapine, 10 mg · kg^- 1 . d^- 1 , orally feeding for 21 days) , with 8 mice in each group. All mice were sacrificed at day 21. Food intake, body weight and tumor size were compared among three groups. Results Gemcitabine group showed significant anti-tumor effects, but adverse effects such as decreasing food intake and body weight was also noted. On days 21, there was no significant difference in tumor size between combination group and gemcitabine group. The tumor inhibition rates of the two groups were 69.13% and 71.60% respectively (P 〉 0.05 ). The food intake of mice and body weight (3.12 ± 0. 11 ) g and (14.68 ± 0.42 )g] in combination group were slightly greater than these of gemcitabine group (2.96 ± 0.14) g and ( 14.38 ± 0.61 ) g, P 〉 0.05 ] , but these parameters were significantly lower than those of control group (4.65 ±0.13)g and ( 17.46 ±0.52)g, P 〈0.05]. Conclusions Gemeitabine chemotherapy showed significant anti-tumor effects. Mirtazapine cannot significantly enhance the anti-tumor effect of gemcitabine. However, mirtazapine could alleviate adverse events of gemcitabine to some extent.
Keywords:Pancreatic neoplasms  Antidepressive agents  Drug therapy  combination  Mirtazapine  Gemcitabine
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号